CS1 A MARKOV MODELLED PHARMACOECONOMIC ANALYSIS OF BIMATOPROST 0.03% (LUMIGAN®) IN THE TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION AS AN ALTERNATIVE TO FILTRATION SURGERY IN ITALY
Authors:
- M VetrugnoMVM Vetrugno
- Tl ChristensenTCTl Christensen
- Pb PoulsenPPPb Poulsen
- J WaltJWJ Walt
- S HolmstromSHS Holmstrom
- 31 December 2003
- journal article
- abstracts
- Published by Elsevier in Value in Health
- Vol. 6 (6) , 628